We haven’t quite decided which adjective best describes the current mood of pharmaceutical sales reps. Disgruntled, demoralized, unappreciated or perhaps more appropriately soon to be unemployed. Now granted we only keep in touch with reps in our wacky world but from what we can tell this lack of self-esteem extends beyond diabetes reps. Yes, as we approach the holidays management is getting ready for what has become an annual event, the purge.
Just doing a quick check of the major insulin companies Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO) and Sanofi (NYSE: SNY) the troops in the field . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.